Magnesium reduces myocardial infarct size via enhancement of adenosine mechanism in rabbits (Q44006843)

28 November 2017

title

Magnesium reduces myocardial infarct size via enhancement of adenosine mechanism in rabbits (English)

1 reference

28 November 2017

0 references

Tomoyuki Matsusaka

1

1 reference

28 November 2017

Naoyuki Hasebe

2

1 reference

28 November 2017

Yin Tie Jin

3

1 reference

28 November 2017

Junichi Kawabe

4

1 reference

28 November 2017

Kenjiro Kikuchi

5

1 reference

28 November 2017

publication date

1 June 2002

1 reference

28 November 2017

published in

Cardiovascular Research

1 reference

28 November 2017

volume

54

1 reference

28 November 2017

issue

3

1 reference

28 November 2017

page(s)

568-575

1 reference

Long-term outcome after intravenous magnesium sulphate in suspected acute myocardial infarction: the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2)

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900253-5

Magnesium therapy in acute myocardial infarction when patients are not candidates for thrombolytic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900253-5

Magnesium Sulfate Reduces Myocardial Infarct Size When Administered Before but Not After Coronary Reperfusion in a Canine Model

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900253-5

Timing of Magnesium Therapy Affects Experimental Infarct Size

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900253-5

Myocardial protective effects of adenosine. Infarct size reduction with pretreatment and continued receptor stimulation during ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900253-5

Effects of ischemia, preconditioning, and adenosine deaminase inhibition on interstitial adenosine levels and infarct size

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900253-5

5′-Nucleotidase: molecular structure and functional aspects

21 January 2018

2 references

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900253-5

21 January 2018

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900253-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Magnesium: Nature's physiologic calcium blocker

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900253-5

Treatment of torsade de pointes with magnesium sulfate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900253-5

Magnesium treatment of ventricular arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900253-5

Adenosine blockade during reperfusion reverses the infarct limiting effect in preconditioned canine hearts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900253-5

Is there a place for magnesium in the treatment of acute myocardial infarction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900253-5

Magnesium in acute myocardial infarction: overview of available evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900253-5

Evaluation of the effect of azapropazone on neutrophil migration in regional myocardial ischaemia/reperfusion injury in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900253-5

Blockade of ATP-sensitive potassium channels increases infarct size but does not prevent preconditioning in rabbit hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900253-5

Dipyridamole potentiates the myocardial infarct size-limiting effect of ischemic preconditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900253-5

Role of adenosine receptor activation in myocardial infarct size limitation by ischaemic preconditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900253-5

The effect of two different diltiazem treatments on infarct size in ischemic, reperfused porcine hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900253-5

Cardioprotective effects of amlodipine in the ischemic-reperfused heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900253-5

Inhibition by magnesium of calcium inward current in heart ventricular muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900253-5

Internal free magnesium modulates the voltage dependence of contraction and Ca transient in rabbit ventricular myocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900253-5

Magnesium deficiency and myocardial infarct size in the dog.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900253-5

Acute myocardial infarction, reperfusion injury, and intravenous magnesium therapy: basic concepts and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900253-5

Myocardial recovery during post-ischaemic reperfusion: Effects of nifedipine, calcium and magnesium

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900253-5

Initial experience with percutaneous transhepatic cardiac catheterization in infants and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900253-5

Ischemic preconditioning increases adenosine release and 5'-nucleotidase activity during myocardial ischemia and reperfusion in dogs. Implications for myocardial salvage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900253-5

5'-Nucleotidase from rat heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900253-5

Inotropic responsiveness of the heart in catecholamine cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900253-5

Benefit of thrombolytic therapy is sustained throughout five years and is related to TIMI perfusion grade 3 but not grade 2 flow at discharge. The European Cooperative Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900253-5

The effects of intravenous infusions of selective adenosine A1-receptor and A2-receptor agonists on myocardial reperfusion injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900253-5

Rabbit hearts for the critical evaluation of drugs to reduce the size of experimentally produced acute myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900253-5

Regulation of cardiac Ca2+ release channel (ryanodine receptor) by Ca2+, H+, Mg2+, and adenine nucleotides under normal and simulated ischemic conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900253-5

10.1016/S0008-6363(02)00253-5

7 January 2021

Identifiers

DOI

1 reference

28 November 2017

1 reference